Anticancer effects of isofraxidin against A549 human lung cancer cells via the EGFR signaling pathway Han Zhang et al, 2018, Molecular Medicine Reports CrossRef
In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration
Qi Zhou et al, 2020, OncoTargets and Therapy CrossRef
Gjb4 serves as a novel biomarker for lung cancer and promotes metastasis and chemoresistance via Src activation Yi-Pei Lin et al, 2019, Oncogene CrossRef
Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells
Yuzhou Shen et al, 2020, Drug Design, Development and Therapy CrossRef